Retinal and Choroidal Alterations in Thyroid-Associated Ophthalmopathy: A Systematic Review

Retinal and Choroidal Alterations in Thyroid-Associated Ophthalmopathy: A Systematic Review

Thyroid-associated ophthalmopathy (TAO), or Graves’ orbitopathy (GO), is a complex autoimmune disorder affecting orbital tissues, often leading to vision-threatening complications such as dysthyroid optic neuropathy (DON). In this systematic review, conducted following PRISMA guidelines, 22 studies...

Full description

Saved in:

Bibliographic Details
Main Authors:	Alexandra Magdalena Ioana, Diana Andrei, Daniela Iacob, Sorin Lucian Bolintineanu
Format:	Article
Language:	English
Published:	MDPI AG 2025-02-01
Series:	Life
Subjects:	thyroid-associated ophthalmopathy thyroid eye disease Graves’ ophthalmopathy Graves’ disease optical coherence tomography retina
Online Access:	https://www.mdpi.com/2075-1729/15/2/293
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prevalence of Graves ophthalmopathy among patients with thyroid disease
by: Erwin D. Palisoc, MD, et al.
Published: (2010-06-01)

Hyperlipidemia and apolipoprotein E are associated with intraocular pressure of thyroid-associated ophthalmopathy in a Chinese population: a cross-sectional study
by: Yu Chen, et al.
Published: (2024-11-01)

The role of IL-6 in thyroid eye disease: an update on emerging treatments
by: Jennifer Murdock, et al.
Published: (2025-04-01)

Correction: The role of IL-6 in thyroid eye disease: an update on emerging treatments
by: Jennifer Murdock, et al.
Published: (2025-07-01)

Practical Guidelines Management of Graves Ophthalmopathy
by: Imam Subekti, et al.
Published: (2020-02-01)

Practical Guidelines Management of Graves Ophthalmopathy
by: Imam Subekti, et al.
Published: (2020-02-01)

Update on pathogenesis and immunology of Graves’ ophthalmopathy
by: Larysa Krajewska-Węglewicz, et al.
Published: (2018-12-01)

Can chimeric antigen receptors – based therapy bring a gleam of hope for thyroid-associated ophthalmopathy and other autoimmune diseases?
by: Zhou Weiyi, et al.
Published: (2025-04-01)

SEARCH FOR TARGET TISSUE IN THE EYE ORBIT FOR AUTOIMMUNE AGGRESSION OF THYROID ANTIBODIES IN ENDOCRINE OPHTHALMOPATHY
by: V. G. Likhvantseva, et al.
Published: (2017-10-01)

Teprotumumab and sensorineural hearing loss: a propensity score-matched retrospective cohort study
by: Maxim John Levy Barnett, et al.
Published: (2025-07-01)

Efficacy and safety of various Intravenous Methylprednisolone regimens in Moderate to Severe Thyroid Eye Disease: A systematic review
by: Ankita Aishwarya, et al.
Published: (2025-08-01)

Rituximab in the treatment of Graves’ disease and endocrine ophthalmopathy. Opportunities and limitations
by: T. S. Panevin, et al.
Published: (2023-10-01)

Radioiodine Thyroid Ablation in Graves′ Hyperthyroidism: Merits and Pitfalls
by: J. Nwatsock, et al.
Published: (2012-01-01)

Emerging therapeutic approaches in graves’ ophthalmopathy: an update on pharmacological interventions
by: Lin Wang, et al.
Published: (2025-07-01)

Causal association between non-thyroidal autoimmune diseases and Graves' ophthalmopathy: A mendelian randomization study
by: Lan Ma, et al.
Published: (2025-02-01)

A Case Report on the Thyroid and Eye Connection: A Deep Dive into Evaluation and Treatment Strategies
by: Iqra Mushtaq, et al.
Published: (2025-06-01)

Validation of Indonesian Graves’ Ophthalmopathy Quality of Life Questionnaire and Its Association with Clinical Activity and Severity of Graves’ Ophthalmopathy
by: Cecilia Anggraini, et al.
Published: (2024-10-01)

Inactive Graves’ orbitopathy: to treat or not to treat?
by: O. G. Panteleeva, et al.
Published: (2023-03-01)

New Method of Calculating the Excess Amount of Soft Tissues of the Orbit in Patients with Endocrine Ophthalmopathy when Planning Operations
by: D. V. Davydov, et al.
Published: (2019-12-01)

Muller-muscle recession for mild to moderate upper-eyelid retraction
by: Victor B. Lopez, MD, et al.
Published: (2005-03-01)

Validation of Indonesian Graves’ Ophthalmopathy Quality of Life Questionnaire and Its Association with Clinical Activity and Severity of Graves’ Ophthalmopathy
by: Cecilia Anggraini, et al.
Published: (2025-01-01)

Extraocular muscle index as a novel indicator of inflammatory condition in graves’ ophthalmopathy patients
by: Fangkun Wu, et al.
Published: (2025-05-01)

Single-cell transcriptomics in thyroid eye disease
by: Sofia Ahsanuddin, et al.
Published: (2024-12-01)

Choroidal profile in patients with inactive thyroid-associated ophthalmopathy
by: Mahsan Samadi, et al.
Published: (2025-04-01)

Optimal timing for cataract surgery in patients with thyroid-associated ophthalmopathy
by: Na Miao, et al.
Published: (2025-04-01)

Surgical Management of Strabismus in Thyroid Ophthalmopathy
by: Vidhya Chandran, et al.
Published: (2020-01-01)

Safety, pharmacokinetics, and potential benefits of TSH-receptor-specific monoclonal autoantibody K1-70TM in Japanese Graves’ disease patients: results of a phase 1 trial
by: Jaeduk Yoshimura Noh, et al.
Published: (2025-08-01)

Retinal and choroidal microvascular analysis by swept-source optical coherence tomography angiography in thyroid-associated ophthalmopathy (TAO) and hyperthyroidism without clinical signs of TAO
by: Congbi Liang, et al.
Published: (2025-12-01)

Machine learning unveils hypoxia-immune gene hub for clinical stratification of thyroid-associated ophthalmopathy
by: Lu Chen, et al.
Published: (2025-07-01)

Radiological Features of Thyroid Eye Disease (TED)
by: Ayushi Agarwal, et al.
Published: (2020-10-01)

A randomized controlled trial on the effect of hydroxychloroquine in mild Graves’ orbitopathy (GO-HCQ): study protocol
by: Chia-Hung Lin, et al.
Published: (2025-08-01)

Negative association between serum calcium and glucocorticoid-induced hypertension in thyroid-associated ophthalmopathy patients treated with methylprednisolone
by: Ling Wang, et al.
Published: (2025-04-01)

HUBUNGAN FAKTOR RISIKO TERHADAP KEJADIAN OPHTHALMOPATHY GRAVES
by: Y. Andressa Nugroho W., et al.
Published: (2019-10-01)

Evaluation of the patients with Grave’s ophthalmopathy after the corticosteroids treatment
by: Janićijević-Petrović Mirjana, et al.
Published: (2012-01-01)

Effects of pulse glucocorticoid treatment on retinal blood flow in patients with active Graves’ orbitopathy
by: Hedayatullah Mohammadi, et al.
Published: (2025-07-01)

Thyroid-Associated Ophthalmopathy in a Hypothyroid Patient
by: Dorotea Filipan, et al.
Published: (2024-01-01)

The Value of MRI and Radiomics for the Diagnostic Evaluation of Thyroid-Associated Ophthalmopathy
by: Weiyi Zhou, et al.
Published: (2025-02-01)

Signatures of Six Autophagy‐Related Genes as Diagnostic Markers of Thyroid‐Associated Ophthalmopathy and Their Correlation With Immune Infiltration
by: Qintao Ma, et al.
Published: (2024-12-01)

Comparative effectiveness of various orbital decompression techniques in treating thyroid-associated ophthalmopathy: a systematic review and meta-analysis
by: Wei Guo, et al.
Published: (2024-12-01)

Targeted immunotherapies for Graves’ thyroidal & orbital diseases
by: Alan Chun Hong Lee, et al.
Published: (2025-03-01)